SCHEMBL30926124

SCHEMBL30926124

N#Cc1ccccc1-c1cc[nH]n1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 1/20 0.42
SLC6A2 P23975 2/20 0.41
SLC6A4 P31645 2/20 0.41
KCNH2 Q12809 1/20 0.41
GABRG2 P18507 1/20 0.41
GABRB3 P28472 1/20 0.41
GABRA5 P31644 1/20 0.41
GABRA3 P34903 1/20 0.41
TRPA1 O75762 1/20 0.39
PTGES O14684 1/20 0.38
TSHR P16473 1/20 0.36
L3MBTL1 Q9Y468 2/20 0.36
GAA P10253 1/20 0.36
MCL1 Q07820 1/20 0.36
ATR Q13535 2/20 0.35
PRKDC P78527 1/20 0.35
ATM Q13315 1/20 0.35
USP8 P40818 1/20 0.34
USP7 Q93009 1/20 0.34
MAP2K1 Q02750 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3401714 1.00 ESR2 (0.42) ESR2SLC6A2SLC6A4KCNH2GABRG2
Hydrochloric Acid SCHEMBL30510206 0.98 ESR2 (0.41) ESR2SLC6A2SLC6A4KCNH2GABRG2
SCHEMBL18300977 0.83 MAP2K1 (0.41) ESR2SLC6A2SLC6A4KCNH2GABRG2
SCHEMBL945479 0.81
SCHEMBL7203838 0.80 MEN1 (0.39) SLC6A2SLC6A4KCNH2GABRG2GABRB3
SCHEMBL31402956 0.76 CHEK1 (0.34) PTGESMCL1
SCHEMBL30322087 0.76 PRMT5 (0.36) GABRG2GABRB3GABRA3USP8USP7
SCHEMBL28242325 0.76 PRMT5 (0.36) TSHRGAAUSP8USP7
SCHEMBL25830894 0.76 KDM4E (0.44) L3MBTL1USP8USP7
Hydrochloric Acid SCHEMBL25378498 0.75 KDM4E (0.43) SLC6A2SLC6A4USP8USP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240101544-A1 INHIBITORS OF QPCTL AND QPCT 858 THERAPEUTICS, INC. 2024-03-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240101544-A1 INHIBITORS OF QPCTL AND QPCT ACAT1, ACAT2, LCAT ESR2 2353/4885SLC6A2 660/4885SLC6A4 1084/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.